RABZMEDA-DSR
RABZMEDA-DSR is a pharmaceutical capsule formulation from SupriMeda containing Rabeprazole and sustained-release Domperidone. It is listed in the gastrointestinal product segment and combines two active pharmaceutical ingredients in a single capsule dosage form.
Rabeprazole belongs to the proton pump inhibitor class, while Domperidone is a prokinetic agent. The formulation is identified by its combination of Rabeprazole 20 mg and Domperidone 30 mg (SR), as recorded in the product documentation. This combination and its specified strengths provide the key identifiers for distinguishing RABZMEDA-DSR from other gastrointestinal formulations in pharmaceutical catalogues.
Supplied in a carton containing 10 strips of 10 capsules each, RABZMEDA-DSR has a clearly defined pack configuration for product identification, inventory management and pharmaceutical procurement. Its brand name, active ingredients, strengths, sustained-release designation and capsule dosage form should be retained consistently across product listings, pharmacy catalogues and institutional purchasing records.
Everything You, Need to Know
10 × 10 capsules, equivalent to 100 capsules per carton.
RABZMEDA-DSR is available as a capsule formulation.
Rabeprazole 20 mg and Domperidone 30 mg (SR) per capsule